Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 4/20 | 0.54 |
| ▸ | MAPK13 | O15264 | 3/20 | 0.50 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.50 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.50 |
| ▸ | PTK2 | Q05397 | 14/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3876294 | 0.91 | MAPK14 (0.59) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3877636 | 0.86 | MAPK14 (0.60) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL5826349 | 0.85 | MAPK14 (0.56) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3874753 | 0.85 | MAPK14 (0.67) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3885924 | 0.85 | MAPK14 (0.59) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3876958 | 0.85 | MAPK14 (0.66) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3874558 | 0.84 | MAPK14 (0.58) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3878247 | 0.84 | MAPK14 (0.58) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3878474 | 0.84 | MAPK14 (0.56) | MAPK14MAPK13MAPK12MAPK11PTK2 | |
| SCHEMBL3875450 | 0.84 | MAPK14 (0.62) | MAPK14MAPK13MAPK12MAPK11PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622610-A1 | 1-(2H-PYRAZOL-3-YL)-3- 4-[1-(BENZOYL)-PIPERIDIN-4-YLMETHYL]-PHENYL -UREA DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS | Aventis Pharmaceuticals Inc. (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004100946-A1 | 1- (2H-PYRAZOL -3-YL) -3YL) {4-`1- (BENZOYL) -PIPERIDIN-4-YLMETHYL!-PHENYL}-UREA DERIVATIVES AND RELATED COMPOUNDS AS INHBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF IMFLAMMATIONS | AVENTIS PHARMACEUTICALS INC. (US) | 2004-11-25 | — | — | WO | disclosed |